Coral Laboratories intimates BSE of its upcoming board meeting on May 30, 2026, pursuant to SEBI LODR Regulation 29.
Agenda includes approval of FY26 standalone audited results and potential final dividend recommendation.
Board will also consider appointments of Internal Auditor and Cost Auditor for FY 2026-27.
Trading window closure is effective from April 1, 2026, until 48 hours after result declaration.